These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 38336839

  • 1. Ruxolitinib induces apoptosis and pyroptosis of anaplastic thyroid cancer via the transcriptional inhibition of DRP1-mediated mitochondrial fission.
    Guo YW, Zhu L, Duan YT, Hu YQ, Li LB, Fan WJ, Song FH, Cai YF, Liu YY, Zheng GW, Ge MH.
    Cell Death Dis; 2024 Feb 09; 15(2):125. PubMed ID: 38336839
    [Abstract] [Full Text] [Related]

  • 2. Alantolactone induces concurrent apoptosis and GSDME-dependent pyroptosis of anaplastic thyroid cancer through ROS mitochondria-dependent caspase pathway.
    Hu Y, Wen Q, Cai Y, Liu Y, Ma W, Li Q, Song F, Guo Y, Zhu L, Ge J, Zeng Q, Wang J, Yin C, Zheng G, Ge M.
    Phytomedicine; 2023 Jan 09; 108():154528. PubMed ID: 36343549
    [Abstract] [Full Text] [Related]

  • 3. Prosapogenin A induces GSDME-dependent pyroptosis of anaplastic thyroid cancer through vacuolar ATPase activation-mediated lysosomal over-acidification.
    Liu Y, Guo Y, Zeng Q, Hu Y, He R, Ma W, Qian C, Hua T, Song F, Cai Y, Zhu L, Ren X, Xu J, Zheng C, Ding L, Ge J, Wang W, Xu H, Ge M, Zheng G.
    Cell Death Dis; 2024 Aug 13; 15(8):586. PubMed ID: 39138191
    [Abstract] [Full Text] [Related]

  • 4. Targeting CDK12-mediated transcription regulation in anaplastic thyroid carcinoma.
    Geng M, Yang Y, Cao X, Dang L, Zhang T, Zhang L.
    Biochem Biophys Res Commun; 2019 Dec 10; 520(3):544-550. PubMed ID: 31615655
    [Abstract] [Full Text] [Related]

  • 5. STAT3 signaling statuses determine the fate of resveratrol-treated anaplastic thyroid cancer cells.
    Wu J, Li YT, Tian XT, Liu YS, Wu ML, Li PN, Liu J.
    Cancer Biomark; 2020 Dec 10; 27(4):461-469. PubMed ID: 31958078
    [Abstract] [Full Text] [Related]

  • 6. The central role of a two-way positive feedback pathway in molecular targeted therapies-mediated pyroptosis in anaplastic thyroid cancer.
    Zhao Q, Feng H, Yang Z, Liang J, Jin Z, Chen L, Zhan L, Xuan M, Yan J, Kuang J, Cheng X, Zhao R, Qiu W.
    Clin Transl Med; 2022 Feb 10; 12(2):e727. PubMed ID: 35184413
    [Abstract] [Full Text] [Related]

  • 7. Torin2 targets dysregulated pathways in anaplastic thyroid cancer and inhibits tumor growth and metastasis.
    Sadowski SM, Boufraqech M, Zhang L, Mehta A, Kapur P, Zhang Y, Li Z, Shen M, Kebebew E.
    Oncotarget; 2015 Jul 20; 6(20):18038-49. PubMed ID: 25945839
    [Abstract] [Full Text] [Related]

  • 8. BET bromodomain inhibitor JQ1 modulates microRNA expression in thyroid cancer cells.
    Mio C, Conzatti K, Baldan F, Allegri L, Sponziello M, Rosignolo F, Russo D, Filetti S, Damante G.
    Oncol Rep; 2018 Feb 20; 39(2):582-588. PubMed ID: 29251329
    [Abstract] [Full Text] [Related]

  • 9. PP121, a dual inhibitor of tyrosine and phosphoinositide kinases, inhibits anaplastic thyroid carcinoma cell proliferation and migration.
    Che HY, Guo HY, Si XW, You QY, Lou WY.
    Tumour Biol; 2014 Sep 20; 35(9):8659-64. PubMed ID: 24867098
    [Abstract] [Full Text] [Related]

  • 10. GANT61 suppresses cell survival, invasion and epithelial-mesenchymal transition through inactivating AKT/mTOR and JAK/STAT3 pathways in anaplastic thyroid carcinoma.
    Gao H, Wang W, Li Q.
    Cancer Biol Ther; 2022 Dec 31; 23(1):369-377. PubMed ID: 35491899
    [Abstract] [Full Text] [Related]

  • 11. CLM29 and CLM24, pyrazolopyrimidine derivatives, have antitumoral activity in vitro in anaplastic thyroid cancer, with or without BRAF mutation.
    Fallahi P, Ferrari SM, La Motta C, Materazzi G, Bocci G, Da Settimo F, Miccoli P, Antonelli A.
    Endocrine; 2016 Jul 31; 53(1):136-44. PubMed ID: 26286966
    [Abstract] [Full Text] [Related]

  • 12. Capsaicin induces mitochondrial dysfunction and apoptosis in anaplastic thyroid carcinoma cells via TRPV1-mediated mitochondrial calcium overload.
    Xu S, Cheng X, Wu L, Zheng J, Wang X, Wu J, Yu H, Bao J, Zhang L.
    Cell Signal; 2020 Nov 31; 75():109733. PubMed ID: 32771398
    [Abstract] [Full Text] [Related]

  • 13. Hesperetin activates the Notch1 signaling cascade, causes apoptosis, and induces cellular differentiation in anaplastic thyroid cancer.
    Patel PN, Yu XM, Jaskula-Sztul R, Chen H.
    Ann Surg Oncol; 2014 Dec 31; 21 Suppl 4(0 4):S497-504. PubMed ID: 24419754
    [Abstract] [Full Text] [Related]

  • 14. Blocking CDK7-Mediated NOTCH1-cMYC Signaling Attenuates Cancer Stem Cell Activity in Anaplastic Thyroid Cancer.
    Doolittle WKL, Zhao L, Cheng SY.
    Thyroid; 2022 Aug 31; 32(8):937-948. PubMed ID: 35822558
    [Abstract] [Full Text] [Related]

  • 15. KLF5 influences cell biological function and chemotherapy sensitivity through the JNK signaling pathway in anaplastic thyroid carcinoma.
    Wang Z, Qiu X, Zhang H, Li W.
    J Biochem Mol Toxicol; 2020 May 31; 34(5):e22469. PubMed ID: 32173973
    [Abstract] [Full Text] [Related]

  • 16. Ophiopogonin D' inhibited tumour growth and metastasis of anaplastic thyroid cancer by modulating JUN/RGS4 signalling.
    Xu T, Zhang W, Zhang Y, Song F, Huang P.
    J Cell Mol Med; 2024 Aug 31; 28(16):e70014. PubMed ID: 39153211
    [Abstract] [Full Text] [Related]

  • 17. Ibuprofen inhibits anaplastic thyroid cells in vivo and in vitro by triggering NLRP3-ASC-GSDMD-dependent pyroptosis.
    Guo H, Ma R, Zhang Y, Yin K, Du G, Yin F, Li H, Wang Z, Yin D.
    Inflammopharmacology; 2024 Feb 31; 32(1):733-745. PubMed ID: 37999895
    [Abstract] [Full Text] [Related]

  • 18. EIF5A2 Is Highly Expressed in Anaplastic Thyroid Carcinoma and Is Associated With Tumor Growth by Modulating TGF- Signals.
    Hao F, Zhu Q, Lu L, Sun S, Huang Y, Zhang J, Liu Z, Miao Y, Jiao X, Chen D.
    Oncol Res; 2020 Sep 01; 28(4):345-355. PubMed ID: 32138807
    [Abstract] [Full Text] [Related]

  • 19. Targeting Super-Enhancer-Driven Oncogenic Transcription by CDK7 Inhibition in Anaplastic Thyroid Carcinoma.
    Cao X, Dang L, Zheng X, Lu Y, Lu Y, Ji R, Zhang T, Ruan X, Zhi J, Hou X, Yi X, Li MJ, Gu T, Gao M, Zhang L, Chen Y.
    Thyroid; 2019 Jun 01; 29(6):809-823. PubMed ID: 30924726
    [Abstract] [Full Text] [Related]

  • 20. Tolfenamic acid induces apoptosis and growth inhibition in anaplastic thyroid cancer: Involvement of nonsteroidal anti-inflammatory drug-activated gene-1 expression and intracellular reactive oxygen species generation.
    Chang JW, Kang SU, Choi JW, Shin YS, Baek SJ, Lee SH, Kim CH.
    Free Radic Biol Med; 2014 Feb 01; 67():115-30. PubMed ID: 24216474
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.